CORT

Gary Charles Robb

Known title: Chief Business OfficerCIK: 0001529655

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 4, 2026

CORT Featured in Low-Beta Healthcare Stock List. Corcept Therapeutics was included in a recent list of low-beta healthcare stocks, highlighting its potential stability amid market concerns about interest rates. The company currently trades within its 52-week range, with a high trailing P/E ratio of 227.7. Analysts maintain an average price target of $141.00, reflecting a wide range of expectations for the stock's future performance.

this person other insiders at CORT

Transaction History

CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▲ Buy$145K
CORT▼ Sell$10K
CORT▲ Buy$19K
CORT▲ Buy$0
CORT▼ Sell$0
CORT▼ Sell$1.2M
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$25K
CORT▲ Buy$55K
CORT▲ Buy$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$4K
CORT▲ Buy$0
CORT▲ Buy$18K
CORT▲ Buy$563K
CORT▼ Sell$6.7M
CORT▼ Sell$12K
CORT▲ Buy$18K
CORT▲ Buy$0
CORT▼ Sell$18K
CORT▲ Buy$18K
CORT▲ Buy$0
CORT▼ Sell$190K
CORT▼ Sell$166K
CORT▲ Buy$19K
CORT▼ Sell$225K
CORT▼ Sell$47K
CORT▲ Buy$71K
CORT▲ Buy$0
CORT▼ Sell$173K
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$15K
CORT▲ Buy$17K
CORT▲ Buy$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▲ Buy$10K
CORT▲ Buy$36K
CORT▼ Sell$556K
CORT▼ Sell$19K
CORT▲ Buy$0
CORT▲ Buy$17K
CORT▼ Sell$147K
CORT▼ Sell$0
CORT▲ Buy$36K
CORT▼ Sell$509K
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▲ Buy$0
CORT▼ Sell$9K
CORT▲ Buy$17K
CORT▼ Sell$111K
CORT▼ Sell$357K
CORT▲ Buy$36K
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▲ Buy$46K
CORT▼ Sell$269K
CORT▼ Sell$22K
CORT▲ Buy$57K
CORT▲ Buy$0
CORT▲ Buy$36K
CORT▼ Sell$334K
CORT▼ Sell$16K
CORT▲ Buy$0
CORT▲ Buy$17K
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$168K
CORT▼ Sell$36K
CORT▲ Buy$49K
CORT▼ Sell$231K
CORT▲ Buy$0
CORT▲ Buy$17K
CORT▼ Sell$164K
CORT▲ Buy$46K
CORT▼ Sell$270K
CORT▲ Buy$0
CORT▲ Buy$17K
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▲ Buy$48K
CORT▲ Buy$0
CORT▼ Sell$337K
CORT▼ Sell$716K
CORT▲ Buy$86K
CORT▲ Buy$197K
CORT▼ Sell$1.5M
CORT▲ Buy$32K
CORT▲ Buy$0
CORT▼ Sell$5K
CORT▼ Sell$125K
CORT▼ Sell$354K
CORT▼ Sell$261K
CORT▼ Sell$1.3M
CORT▲ Buy$26K
CORT▲ Buy$0
CORT▲ Buy$348K
CORT▼ Sell$2.5M
CORT▲ Buy$68K
CORT▼ Sell$1.2M
CORT▼ Sell$120K
CORT▼ Sell$3K
CORT▼ Sell$562K
CORT▼ Sell$123K
CORT▼ Sell$185K
CORT▼ Sell$981K
CORT▼ Sell$17K
CORT▼ Sell$132K
CORT▲ Buy$400K
CORT▼ Sell$1.7M

We use analytics to understand how market-wall is used. No personal data is sold.